- Home
- CLDI vs AIIOW Comparison
CLDI vs AIIOW Comparison
Compare CLDI & AIIOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- AIIOW
- Stock Information
- Founded
- CLDI 2014
- AIIOW N/A
- Country
- CLDI United States
- AIIOW United Arab Emirates
- Employees
- CLDI N/A
- AIIOW N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- AIIOW Auto Manufacturing
- Sector
- CLDI Health Care
- AIIOW Industrials
- Exchange
- CLDI Nasdaq
- AIIOW Nasdaq
- Market Cap
- CLDI 20.2M
- AIIOW 19.0M
- IPO Year
- CLDI N/A
- AIIOW N/A
- Fundamental
- Price
- CLDI $1.60
- AIIOW $0.05
- Analyst Decision
- CLDI
- AIIOW
- Analyst Count
- CLDI 0
- AIIOW 0
- Target Price
- CLDI N/A
- AIIOW N/A
- AVG Volume (30 Days)
- CLDI 484.3K
- AIIOW N/A
- Earning Date
- CLDI 11-11-2025
- AIIOW N/A
- Dividend Yield
- CLDI N/A
- AIIOW N/A
- EPS Growth
- CLDI N/A
- AIIOW N/A
- EPS
- CLDI N/A
- AIIOW N/A
- Revenue
- CLDI N/A
- AIIOW N/A
- Revenue This Year
- CLDI N/A
- AIIOW N/A
- Revenue Next Year
- CLDI N/A
- AIIOW N/A
- P/E Ratio
- CLDI N/A
- AIIOW N/A
- Revenue Growth
- CLDI N/A
- AIIOW N/A
- 52 Week Low
- CLDI $1.51
- AIIOW N/A
- 52 Week High
- CLDI $46.68
- AIIOW N/A
- Technical
- Relative Strength Index (RSI)
- CLDI 30.60
- AIIOW N/A
- Support Level
- CLDI $1.51
- AIIOW N/A
- Resistance Level
- CLDI $1.68
- AIIOW N/A
- Average True Range (ATR)
- CLDI 0.10
- AIIOW 0.00
- MACD
- CLDI 0.14
- AIIOW 0.00
- Stochastic Oscillator
- CLDI 22.97
- AIIOW 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.